Thermo Fisher Scientific and Verici DX Collaborate on Pre-Transplant Assay
Verici Dx signed a licensing agreement with Thermo Fisher on an assay for pre-transplant prognostic testing of early kidney rejection risks.
Category: Transfusion & Transplantation Tests
Transfusion & Transplantation Tests
Latest
Transfusion & Transplantation Tests
Latest
Test Shows Immune Response to Covid-19 after Organ Transplant
With the test, the team demonstrated organ transplant patients are very capable of achieving a good immune response to covid-19 despite immunosuppression.
Transfusion & Transplantation Tests
Latest
Quality Control Media Help to Reduce Sepsis among Patients Requiring Platelet Transfusion
BD’s quality control media for platelet testing have been CE marked and cleared by FDA.
FDA Approves DNA-Based Test to Determine Blood Compatibility
The molecular test is the first of its type approved to report genotypes as final results.
Read More
The Laboratory’s Role in Delivering High-Value Care
Blood and test utilization management programs can improve patient care while reducing health system costs.
Read More
FDA Approves Grifols ID CORE XT Test
The molecular red blood cell typing test offers the shortest time to reportable results for US hospitals, reference labs, and blood centers.
Read More
Mayo Medical Laboratories, National Decision Support Co Offer Comprehensive Approach to Patient Blood Management
CareSelect Blood features 100 curated transfusion guidelines authored and maintained by the Mayo Clinic.
Read More
Natera Announces New Clinical Utility Data and Issuance of CPT Code for NIPT in Twin Pregnancies
A noninvasive prenatal test for zygosity in twin pregnancies enables obstetricians to triage patients and avoid both overtreatment and undertreatment.
Read MoreResearch Demonstrates Parsortix Workflow for Culturing CTCs
The research developed an optimized workflow for the recovery and culturing of CTCs from a simple blood test to produce an effective ex vivo culture of an individual patient’s cancer cells.
Read More
FDA Clears Ortho Clinical Diagnostics Middleware
The customizable middleware system centralizes laboratory operations and workflow across hospitals and networks, allowing blood banks and their data to be confidently managed through one central terminal.
Read More
Quality Control Product Designed for Column Agglutination Technology
MQC-CAT from Hemo Bioscience includes both positive and negative red cells and sera.
Read More
Capillary Blood Sampling
For point-of-care hemoglobin testing, good capillary blood sampling practices are vitally important.
Read More
FDA Approves First Test for Screening Zika Virus in Blood Donations
FDA has approved the Cobas Zika test intended to detect the Zika virus in blood donations.
Read More
Natera’s Noninvasive Prenatal Test Now Available for Screening Twin Pregnancies
The Panorama noninvasive prenatal test is now validated to screen twin pregnancies for zygosity and chromosomal abnormalities.
Read More
FDA Licenses Blood Grouping Reagents for Extended Phenotype Testing
The suite of reagents from Ortho Clinical Diagnostics is used to determine the status of a designated antigen on human red blood cells.
Read More
Select American Red Cross Blood Donations Screened for Babesia Parasite Using Grifols Assay
The American Red Cross laboratory in Charlotte, NC, is now screening blood samples collected in the states of New Hampshire, New Jersey, Maine, Maryland, Pennsylvania, and Vermont, using the Procleix Babesia assay under an investigational new drug study.
Read More
August/September 2017 Product Spotlight: Hematology, Blood Banking, and Organ Transplantation
This month’s issue features hematology, blood banking, and organ transplantation products from such companies as Abbott, Advanced Instruments, Helmer Scientific, and Ortho Clinical Diagnostics.
Read More
April 2017 Product Spotlight: Emerging Technologies, Part 2
This month’s issue features emerging technologies from such companies as Clinical Genomics, Hamilton Storage, and Symcel.
Read More